eFigure 1. Schematic overview of NoAAC PR02 trial workflow. Data collection was implemented in an electronic data capture (EDC) system recording clinical data along with patient generated health data (consisting of validated patient reported outcome measures, and longitudinal peak expiratory flow rate recorded into a smartphone app)
Multiple Imputation
Multiple imputation was used to address missing covariate values. With a survival outcome, the event indicator, the Nelson-Aalen estimator of the cumulative hazard rate, and covariates were included in the imputation model 6 . We repeated the imputation five times, independently. The imputed datasets were analyzed separately using Cox proportional hazards models. parameter estimates were averaged over five sets of analysis results. The variance estimators of the averaged parameters were estimated using Rubin's multiple imputation 7 .
Propensity Score Matching
Propensity score matching (PSM) addressed the effect of observed confounders. iSGS is a rare disease with a limited evidence base. Thus, we We selected covariates known to affect treatment selection. These primarily included sociodemographic characteristics (age, highest education level, and marital status). These variables have demonstrated associations with the ability to travel large distances to specific medical centers, or to affect how severe a patient's disease was at presentation Additionally, we included variables believed to be related to the outcome but not necessarily the treatment to reduce bias. 8 Comorbidity burden captured by the Charlson comorbidity index score, as well as specific comorbid conditions 
Similar distribution (balance) was assessed by
splitting the sample by quintiles, and then verifying an equivalent mean propensity score in the treatment and comparison groups within each quintile. 9 Unbalanced quintiles were split into smaller blocks, and balance was achieved (Figure S3) .
We verified successful matching by estimating the effect of treatment on disease outcomes (Table S1 ).
Proposed maximum standardized differences for specific covariates range from 10 to 25 percent. 10,11 Figure S3 . Verification of similar distribution or "balance" in the treated (ERMT) and comparison (ED) groups. Distribution estimated by splitting the sample by quintiles, followed by verification of equivalence of mean propensity score in the treatment and comparison groups within each of the five quintiles. Unbalanced quintiles were split into smaller blocks, where balance was achieved When employing PSM to compare the probability of recurrent procedure between the ED and ERMT groups, we saw consistent results with our prior standard models. ED had a hazard ratio of 2.77 (IQR:
1.4-5.5), and this effect persisted in PSM models employing multiple imputation: ED vs. ERMT HR:
3.16 (IQR: 1.8 -5.5) ( Table S2 ) Table S2 . Propensity score matched models comparing rate of disease recurrence after surgical treatment*. ED was inferior to ERMT (HR 2.77, 95% CI 1.4 -5.5), and this effect persisted in PSM models accounting for missing data (ED vs. ERMT, HR 3.16, 95% CI 1.8 -5.5). *Since there was only one recurrent procedure in the CTR group, we did not compare adjusted recurrent procedure rates between CTR and the other two groups.
